More Cancer Mutations, Better Immunotherapy Outcomes

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

Considering Genomic Research?
Fields marked in * is mandatory to fill


2023 © MedGenome • All Rights Reserved
Request a Quote